Exact Mass: 528.2525
Exact Mass Matches: 528.2525
Found 237 metabolites which its exact mass value is equals to given mass value 528.2525
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
ent-6R,16bOH,17-Trihydroxy-7-oxo-6,7-seco-19,6-kauranolide 6-O-glucoside
Constituent of Phaseolus coccineus (scarlet runner bean) [DFC]. ent-6R,16bOH,17-Trihydroxy-7-oxo-6,7-seco-19,6-kauranolide 6-O-glucoside is found in pulses. ent-6R,16bOH,17-Trihydroxy-7-oxo-6,7-seco-19,6-kauranolide 6-O-glucoside is a constituent of Phaseolus coccineus (scarlet runner bean) [DFC]
Chaetoglobosin A
A cytochalasan alkaloid isolated from Chaetomium globosum and Calonectria morganii. CONFIDENCE isolated standard
Chaetoglobosin D
A cytochalasan alkaloid found in Chaetomium globosum and Chaetomium brasiliense.
Chaetoglobosin B
A natural product found in Chaetomium globosum and Chaetomium subaffine.
(13E,17E,21E)-6,7beta-epoxy-19beta-hydroxy-10-indol-3-yl-16alpha,18-dimethyl-[13]cytochalasa-13,17,21-triene-1,20,23-trione|Chaetoglobosin A|chaetoglobosin-A
7-deacetyl-7-benzoyl-14,15-epoxyazadiradione|7-desacetyl-7-benzoylepoxyazadiradione
19-O-beta-D-Glucopyranoside-楼?脥2alpha楼?脫6alpha楼?脦-2,6,18,19-Tetrahydroxy-8,13-labdadien-15,16-olide
1alpha-O-(beta-D-glucopyranosyl)enmenol|1alpha-O-beta-D-glucopyranosylenmenol|ent-7beta,20-epoxykaur-16-ene-1beta,6alpha,7alpha,14alpha,15alpha-pentanol 1-O-beta-D-glucopyranoside
(3-Hydroxy-5-oxo-4-phenyl-5H-furan-2-ylidene)-phenylacetic Acid 6-hydroxy-1,7(11)-humuladienyl-10-yl ester
C32H36N2O5_(3S,3aR,4S,6S,6aR,7E,10S,11Z,13R,15E,17aR)-6,13-Dihydroxy-3-(1H-indol-3-ylmethyl)-4,10,12-trimethyl-5-methylene-2,3,3a,4,5,6,6a,9,10,13-decahydro-1H-cyclotrideca[d]isoindole-1,14,17-trione
Chaetoglobosin C
A cytochalasan alkaloid found in Chaetomium globosum and Chaetomium subaffine. CONFIDENCE isolated standard
Ala Ile Tyr Tyr
Ala Leu Tyr Tyr
Ala Tyr Ile Tyr
Ala Tyr Leu Tyr
Ala Tyr Tyr Ile
Ala Tyr Tyr Leu
Phe Ile Ser Tyr
Phe Ile Tyr Ser
Phe Leu Ser Tyr
Phe Leu Tyr Ser
Phe Ser Ile Tyr
Phe Ser Leu Tyr
Phe Ser Tyr Ile
Phe Ser Tyr Leu
Phe Thr Val Tyr
Phe Thr Tyr Val
Phe Val Thr Tyr
Phe Val Tyr Thr
Phe Tyr Ile Ser
Phe Tyr Leu Ser
Phe Tyr Ser Ile
Phe Tyr Ser Leu
Phe Tyr Thr Val
Phe Tyr Val Thr
His His His Val
His His Val His
His Lys Met Asn
His Lys Asn Met
His Met Lys Asn
His Met Asn Lys
His Asn Lys Met
His Asn Met Lys
His Val His His
Ile Ala Tyr Tyr
Ile Phe Ser Tyr
Ile Phe Tyr Ser
Ile Ser Phe Tyr
Ile Ser Tyr Phe
Ile Tyr Ala Tyr
Ile Tyr Phe Ser
Ile Tyr Ser Phe
Ile Tyr Tyr Ala
Lys His Met Asn
Lys His Asn Met
Lys Met His Asn
Lys Met Asn His
Lys Asn His Met
Lys Asn Met His
Leu Ala Tyr Tyr
Leu Phe Ser Tyr
Leu Phe Tyr Ser
Leu Ser Phe Tyr
Leu Ser Tyr Phe
Leu Tyr Ala Tyr
Leu Tyr Phe Ser
Leu Tyr Ser Phe
Leu Tyr Tyr Ala
Met His Lys Asn
Met His Asn Lys
Met Lys His Asn
Met Lys Asn His
Met Asn His Lys
Met Asn Lys His
Asn His Lys Met
Asn His Met Lys
Asn Lys His Met
Asn Lys Met His
Asn Met His Lys
Asn Met Lys His
Ser Phe Ile Tyr
Ser Phe Leu Tyr
Ser Phe Tyr Ile
Ser Phe Tyr Leu
Ser Ile Phe Tyr
Ser Ile Tyr Phe
Ser Leu Phe Tyr
Ser Leu Tyr Phe
Ser Tyr Phe Ile
Ser Tyr Phe Leu
Ser Tyr Ile Phe
Ser Tyr Leu Phe
Thr Phe Val Tyr
Thr Phe Tyr Val
Thr Val Phe Tyr
Thr Val Tyr Phe
Thr Tyr Phe Val
Thr Tyr Val Phe
Val Phe Thr Tyr
Val Phe Tyr Thr
Val His His His
Val Thr Phe Tyr
Val Thr Tyr Phe
Val Tyr Phe Thr
Val Tyr Thr Phe
Tyr Ala Ile Tyr
Tyr Ala Leu Tyr
Tyr Ala Tyr Ile
Tyr Ala Tyr Leu
Tyr Phe Ile Ser
Tyr Phe Leu Ser
Tyr Phe Ser Ile
Tyr Phe Ser Leu
Tyr Phe Thr Val
Tyr Phe Val Thr
Tyr Ile Ala Tyr
Tyr Ile Phe Ser
Tyr Ile Ser Phe
Tyr Ile Tyr Ala
Tyr Leu Ala Tyr
Tyr Leu Phe Ser
Tyr Leu Ser Phe
Tyr Leu Tyr Ala
Tyr Ser Phe Ile
Tyr Ser Phe Leu
Tyr Ser Ile Phe
Tyr Ser Leu Phe
Tyr Thr Phe Val
Tyr Thr Val Phe
Tyr Val Phe Thr
Tyr Val Thr Phe
Tyr Tyr Ala Ile
Tyr Tyr Ala Leu
Tyr Tyr Ile Ala
Tyr Tyr Leu Ala
WYE-687
WYE-687 is an ATP-competitive mTOR inhibitor with an IC50 of 7 nM. WYE-687 concurrently inhibits activation of mTORC1 and mTORC2. WYE-687 also inhibits PI3Kα and PI3Kγ with IC50s of 81 nM and 3.11 μM, respectively. WYE-687 is an ATP-competitive mTOR inhibitor with an IC50 of 7 nM. WYE-687 concurrently inhibits activation of mTORC1 and mTORC2. WYE-687 also inhibits PI3Kα and PI3Kγ with IC50s of 81 nM and 3.11 μM, respectively.
(1R,3S)-3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine,(2R,3R)-2,3-dibenzoyloxybutanedioic acid
Fentanyl citrate
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate
7-Deacetyl-7-benzoylepoxyazadiradione
A limonoid that is epoxyazadiradione in which the acetyl group has been replaced by a benzoyl group. It has been isolated from Azadirachta indica.
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] [(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate
(1E,4S,5E,11aR,14S,14aR,15S,15aR,16bR)-14-(1H-indol-3-ylmethyl)-4,6,15,15a-tetramethyl-9,10,14,14a,15,15a,16a,16b-octahydro-3H-cyclotrideca[d]oxireno[f]isoindole-7,8,11,12(4H,13H)-tetrone
ent-6R,16bOH,17-Trihydroxy-7-oxo-6,7-seco-19,6-kauranolide 6-O-glucoside
(1s,4r,8r,9s,11e,14s,16r,17s,18r,19s)-6,21-dihydroxy-19-(1h-indol-3-ylmethyl)-7,9,16,17-tetramethyl-15-oxa-20-azapentacyclo[11.8.0.0¹,¹⁸.0⁴,⁸.0¹⁴,¹⁶]henicosa-6,11,20-triene-2,5-dione
(1r,2s,3s,5s,7r,8s,9s,10s,11r,15s)-12,12-dimethyl-6-methylidene-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-7,9,10,15-tetrol
6,21-dihydroxy-19-(1h-indol-3-ylmethyl)-7,9,16,17-tetramethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-3,7,11,20-tetraene-2,5-dione
(3s,3ar,6s,6ar,10s,13r,17as)-1,6,13-trihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,6h,6ah,9h,10h,13h-cyclotrideca[d]isoindole-14,17-dione
12,12-dimethyl-6-methylidene-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-7,9,10,15-tetrol
(3z,6r,7z,9s,11z,13r,14s,16r,17s,18r,19s)-6,21-dihydroxy-19-(1h-indol-3-ylmethyl)-7,9,16,17-tetramethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-3,7,11,20-tetraene-2,5-dione
1-hydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,5h,6ah,9h,10h,15h,16h-cyclotrideca[d]isoindole-6,13,14,17-tetrone
(3s,3ar,6s,6ar,10r,13s,17as)-1,6,13-trihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,6h,6ah,9h,10h,13h-cyclotrideca[d]isoindole-14,17-dione
(3-hydroxy-5-oxo-4-phenyl-5h-furan-2-ylid-ene)-phenylaceticacid 6-hydroxy-1,7(11)-humuladienyl-10-yl ester
{"Ingredient_id": "HBIN008683","Ingredient_name": "(3-hydroxy-5-oxo-4-phenyl-5h-furan-2-ylid-ene)-phenylaceticacid 6-hydroxy-1,7(11)-humuladienyl-10-yl ester","Alias": "NA","Ingredient_formula": "C33H36O6","Ingredient_Smile": "CC1CCC(C(=C)CCC(C(C=C1)(C)C)OC(=O)C(=C2C(=C(C(=O)O2)C3=CC=CC=C3)O)C4=CC=CC=C4)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10578","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
adenostemmmoside d
{"Ingredient_id": "HBIN014699","Ingredient_name": "adenostemmmoside d","Alias": "NA","Ingredient_formula": "C26H40O11","Ingredient_Smile": "CC12CCCC(C1CCC34C2C(CC(C3)C(C4=O)(CO)O)O)(C)C(=O)OC5C(C(C(C(O5)CO)O)O)O","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "23668","TCMSP_id": "NA","TCM_ID_id": "7158","PubChem_id": "NA","DrugBank_id": "NA"}